Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

Summary

The sponsor electively terminated the study because the risk mitigation measures, deemed necessary after an unforeseen safety event, could not be effectively implemented within this protocol while maintaining study timelines within a reasonable time frame.

Timeline

Start

2011-06

Primary completion

2011-11

Completion

—

Drugs

Indications